|Bid||0.00 x 800|
|Ask||0.00 x 2900|
|Day's Range||50.52 - 54.96|
|52 Week Range||19.83 - 94.75|
|Beta (5Y Monthly)||0.97|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 19, 2024 - Feb 23, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||71.19|
Subscribe to Yahoo Finance Plus to view Fair Value for APLS
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
WALTHAM, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced that the company will host a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023, at 10:00 a.m. ET. The event will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event. Abo
Jazz (JAZZ) reports mixed results in third-quarter 2023. However, shares rose 2.5% post the announcement, likely on the back of raised guidance for 2023.